Fairence® is a a scientifically designed pigment lightening cream enhanced by Xcelarev®, a patented delivery system incorporating three key ingredients, namely Tranexamic acid, Niacinamide and Lactobionic acid, to tackle pigmentation issues such as melasma. Click here to read our media release for more details.
Under this partnership, they will be granted exclusive rights to distribute Ceradan® products, such as Ceradan® Skin Barrier Repair Cream, with the exception of Ceradan® Advanced. Click here to read our media release for more details.
MAGNEZIX® is a magnesium alloy metallic implant that can be reabsorbed by the body. Unlike common metal implants, patients now can have a quicker and safer recovery, as they do not need to undergo another surgical intervention to remove such implants. Click here to read our media release for more details.
We are delighted to be able to forge a collaboration with Lundbeck, a globally renowned player in the pharmaceutical domain. Through this exclusive partnership, we will be bringing world class healthcare treatments to the Vietnamese public. Click here to read our media release for more details.
Our collaboration with A*STAR through the MoU with A*ccelerate is a reflection of our commitment to grow through innovation. Click here to read our media release for more details.
Hyphens is currently licensing sugar-based surfactant micro-emulsions technology from A*STAR’s Institute of Chemical and Engineering Sciences (ICES). By leveraging A*STAR’s research and development capabilities, it is envisioned that this MoU will enable Hyphens to develop innovative and differentiated dermatological products to address unmet market needs.
Hyphens is a Singapore-headquartered ASEAN specialty pharma company. Operating in six countries across the region, Hyphens has a strong medical, regulatory and commercial capability. Dermatology is a key therapeutic focus field where Hyphens markets products under the brands “Ceradan” and “TDF”.
We successfully achieved full house for two of our supported symposiums delivered by key speakers from Germany and Singapore. The first symposium was on the advancement in atopic dermatitis and COPES, featuring our study in collaboration with KK Women’s and Children’s Hospital and National Skin Centre (Ceradan®). The second symposium was on urticaria and the clinical relevance of PAF (Rupafin®).
Running into its 11th year, their congress was well attended by 800 doctors from South East Asia. Besides having a booth, Hyphens had two lectures delivered by key opinion leaders from Malaysia and Indonesia. The first topic was on nasal irrigation in children (Sterimar®) and the second topic was on understanding skin barrier and role of ceramide-dominant emollients (Ceradan®) in AD management.
Sterimar™ is voted Best of The Best in Baby Nasal Relief by Parents World’s panel of paediatricians and parents in Singapore!
Click here to read more.
This event was jointly organized by Faculty of Medicine University of Indonesia – Dr Cipto Mangunkusumo Hospital (RSCM), Indonesian ORL HNS Society (PP PERHATI-KL) and ASEAN Rhinology Society. Sterimar® Award was given out to the best Research Presentation during this event.
Like the first AADS, we welcomed back our esteemed keynote speaker, Prof Mike Cork who delivered a concise lecture about how he manages difficult AD. Many delegates took away practical tips which would be relevant and useful in their own respective practices. Dr Mark Koh and Dr Hidajati who are heads of the hospital department touched on patient education and case report of Ceradan®.
Article written by Discovery Reports as it appeared in the South China Morning Post Singapore National Day Report in 2013. Read more
Hyphens hosted the Sterimar Award in conjunction with the JiFESS Organising Committee. The Sterimar Award is for best research paper presented at the JIFESS event. This is the first year the Sterimar® Award is awarded. The winner, Dr Edo Wira Candra from Bandung, gets a sponsorship to the ASEAN ENT Congress in Cebu on March 21 to 23, 2013.